Evogene (EVGN)
$1.37 $0.00 (0.00%) 4:38 PM 12/13/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$9.94M -
Day's Range
$1.30 - $1.33 -
Volume
57,719 -
52 Week Low / High
$1.40 - $10.40 -
PE Ratio
- -
PEG Ratio
- -
Dividend Frequency
-
EVGN's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 2
- Strong Buy
- 0
- Buy
- 0
- Hold
- 0
- Sell
- 0
- Strong Sell
- $3.62
- Target Price
Company News
-
ICL and Lavie Bio Leverage Artificial Intelligence to Make Significant Advancement in Development of Yield Increasing Bio-Stimulants — Jul 17th, 2024
More than one dozen novel microbes identified for row crops suffering from extreme weather conditions TEL AVIV and REHOVOT, Israel, July 17, 2024 /PRNewswire/ -- ICL (NYSE: ICL) (TASE: ICL), a leading global specialty minerals company, and Lavie Bio Ltd., a leading ag-biologicals company...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$